financetom
Business
financetom
/
Business
/
Elbit Systems Shares Are Down Today: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Elbit Systems Shares Are Down Today: What's Going On?
Mar 5, 2024 6:18 AM

Elbit Systems Ltd. ( ESLT ) shares are trading lower after it disclosed that it expects to record non-cash expenses of approximately $52 million in the fourth quarter of 2023. 

The expenses are related to the write-off of inventory due to the closing of an underperforming subsidiary with limited synergies and contract assets related to a discontinued project managed under the subsidiary.

The company says that around $34 million of the expenses are related to an uncollectible balance of contract assets under the discontinued project. 

Apart from this, Elbit Systems ( ESLT ) identified about $18 million of the expenses related to the restructuring and discontinuing the subsidiary’s activities. 

The company plans to release the fourth quarter and full year 2023 financial results on Tuesday, March 26, 2024.

Last month, the company secured a contract worth around $300 million to provide weapon, reconnaissance, driving, and situational awareness systems for roughly 230 armored vehicles to a European client.

Price Action: ESLT shares are down 1.63% at $217.01 premarket on the last check Tuesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eli Lilly to invest over $1 billion in India to expand manufacturing capacity
Eli Lilly to invest over $1 billion in India to expand manufacturing capacity
Oct 6, 2025
By Rishika Sadam (Reuters) -Eli Lilly ( LLY ) will invest more than $1 billion in India in the coming years to boost manufacturing and supply through local drugmakers, the company said on Monday, as it seeks to tap into skilled workforce to bolster its global manufacturing expansion. The collaborations aim to increase the availability of Lilly's key drugs, including...
Market Chatter: Eli Lilly to Invest More Than $1 Billion in India Manufacturing Capacity
Market Chatter: Eli Lilly to Invest More Than $1 Billion in India Manufacturing Capacity
Oct 6, 2025
04:19 AM EDT, 10/06/2025 (MT Newswires) -- Eli Lilly ( LLY ) plans to invest more than $1 billion in India in the years ahead to increase manufacturing and supply via local drugmakers, Reuters reported Monday, citing the company. Through various partnerships, Lilly intends to increase the availability of its main drugs, including those for obesity, diabetes, Alzheimer's, cancer and...
Framework deal for European space giant will require some weeks, source says
Framework deal for European space giant will require some weeks, source says
Oct 6, 2025
ROME (Reuters) -A framework agreement between Italy's Leonardo and France's Thales and Airbus for a new European space giant will require some weeks, a source with knowledge of the matter said on Monday. The parties are still considering some key points of the alliance and the boards of the three companies will need to discuss them, the source added. ...
AstraZeneca Partner Daiichi Sankyo Says Breast Cancer Drug Demonstrates Improvements in Primary Endpoints in Phase 3 Trial
AstraZeneca Partner Daiichi Sankyo Says Breast Cancer Drug Demonstrates Improvements in Primary Endpoints in Phase 3 Trial
Oct 6, 2025
04:14 AM EDT, 10/06/2025 (MT Newswires) -- AstraZeneca ( AZN ) and Daiichi Sankyo said Monday that their breast cancer drug Datroway demonstrated statistically significant and clinically meaningful improvement in the primary endpoints of overall survival and progression-free survival compared with chemotherapy in a phase 3 trial. Datroway had a safety profile consistent with previous trials in the same disease,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved